Related Experiment Video
Updated: Sep 23, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Patchouli alcohol suppresses castration-resistant prostate cancer progression by inhibiting NF-κB signal pathways
Jian Cai1, Juan Zhao1, Ping Gao1
1Department of Urology and Andrology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Background:
There is evidence that patchouli alcohol (PA) has cytotoxic effects on human cancer cell lines, including inhibiting cell growth, migration, and invasion. However, the exact molecular mechanism of PA in human castration-resistant prostate cancer (CRPC) cells remains unclear.
Methods:
DU145 and PC-3 cells were treated with different concentrations of PA for 48 h. Cell counting kit-8 (CCK-8), colony formation, and 5-ethynyl-2'-deoxyuridine (EdU) staining were used to detect cell proliferation. Scratch tests and transwell assays were used to detect cell migration and invasion. TdT-mediated dUTP nick-end labeling (TUNEL) staining and flow cytometry were performed to examine apoptosis and mitochondrial membrane potential. The expression of the apoptosis- and migration-related proteins and the phosphorylation of the nuclear factor kappa -B (NF-κB) cells were detected by Western blot. A chromatin immunoprecipitation (ChIP) analysis was conducted to examine NF-κB p65 binding to the myeloid cell leukemia-1 (Mcl-1) promoter. A xenograft model of nude mice was established to verify the anticancer effects of PA in vivo.
Results:
PA inhibited the proliferation, migration, and invasion, and induced the apoptosis of the DU145 and PC-3 cells in a concentration-dependent manner, and was accompanied by mitochondrial membrane potential depolarization, the upregulation of cleaved caspase-3, cleaved poly ADP-ribose polymerase (PARP) and Bcl-2-associated X protein (Bax), and the downregulation of B-cell lymphoma-2 (Bcl-2), Ki67, and Mcl-1. In relation to the mechanism, PA significantly downregulated the phosphorylation of inhibitor of NF-κB α (IκBα) and p65 and the expression of matrix metalloprotein (MMP)-2, MMP-7, MMP-9, and vascular endothelial growth factor (VEGF). PA prevented p65 binding to the Mcl-1 promoter by inactivating NF-κB p65, downregulated the transcription of Mcl-1, and the silencing of p65 increased the sensitivity of the CRPC cells to PA-induced apoptosis. The overexpression of Mcl-1 significantly reversed the PA-induced apoptosis of the CRPC cells. Additionally, consistent with our in-vitro study, PA inhibited tumor growth in the mouse xenograft model.
Conclusions:
We found that PA inhibits the growth, migration, and invasion of CRPC cells in vitro and in vivo by inducing an apoptosis mechanism and inhibiting NF-κB activity. Our findings may provide therapeutic targets for this malignant tumor.
Insights
Patchouli alcohol (PA) effectively inhibits prostate cancer cell growth, migration, and invasion by inducing apoptosis and suppressing NF-κB signaling. These findings highlight PA as a potential therapeutic agent for castration-resistant prostate cancer.
Area of Science:
- Natural Product Chemistry
- Cancer Biology
- Molecular Pharmacology
Background:
- Patchouli alcohol (PA) exhibits cytotoxic effects on cancer cell lines.
- The precise molecular mechanisms of PA in castration-resistant prostate cancer (CRPC) are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the effects of PA on CRPC cells.
- To evaluate the in vitro and in vivo anticancer potential of PA.
Main Methods:
- Cell proliferation, migration, invasion, and apoptosis assays were performed on DU145 and PC-3 cells treated with PA.
- Western blot analysis was used to assess protein expression and NF-κB signaling.
- Chromatin immunoprecipitation (ChIP) identified NF-κB p65 binding to the Mcl-1 promoter.
- A xenograft mouse model was used to validate in vivo efficacy.
Main Results:
- PA inhibited proliferation, migration, and invasion while inducing apoptosis in CRPC cells in a dose-dependent manner.
- PA downregulated NF-κB signaling, including IκBα and p65 phosphorylation, and reduced Mcl-1 expression.
- PA suppressed tumor growth in a xenograft mouse model.
Conclusions:
- PA demonstrates significant in vitro and in vivo anticancer activity against CRPC by inducing apoptosis and inhibiting NF-κB signaling.
- PA's mechanism involves suppressing NF-κB-mediated Mcl-1 transcription.
- These findings suggest PA as a potential therapeutic candidate for CRPC.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Drugs that Stabilize Microtubules

